Clinical Trials Logo

Clinical Trial Summary

Contrast media induced nephropathy (CIN) is considered to be a serious complication in patient who underwent coronary angiogram (CAG). The pathogenesis of CIN does not well understood. The probable one is the contrast media makes the afferent vessel in glomeruli constrict and results in renal shut down. Limb ischemic preconditioning, a procedure that makes muscles become ischemic and adapt themselves to produce some cytokines for signaling the vessel more dilated. After the reperfusion, these cytokines are getting back to systemic circulation and effect the afferent vessel in glomeruli to become more dilated and prevent CIN.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms

  • Serum Creatinine Before and After Coronary Angiogram
  • Serum Cystatin C Before and After Coronary Angiogram

NCT number NCT01763034
Study type Interventional
Source Ramathibodi Hospital
Contact SIRAPAT POONVUTIKUL, MD
Phone 66891038796
Email boybm027@hotmail.com
Status Recruiting
Phase N/A
Start date February 2013
Completion date March 2014